1. Editor-in-Chief’s Commentary: Gene Penetrance, Therapeutic Targets, and Regulatory Science

   • Stephen P. Spielberg

   Commentary 30 December 2013 Pages: 289 - 290

2. Associate Editor’s Commentary: Measuring Responsibility

   • Peter J. Pitts

   Commentary 30 December 2013 Pages: 291 - 293

3. Summary of DIA Workshop on Co-Development of Personalized Medicine and In Vitro Diagnostic Companion Devices

   • Lisa Palladino Kim
   • Jeffrey N. Stuart
   • James A. Boiani

   DIA Workshops 30 December 2013 Pages: 294 - 298

4. Transparency at the EMA: More Evidence Is Needed

   • Ragnar E. Löfstedt

   Regulatory Science 30 December 2013 Pages: 299 - 300

5. Achieving a Culture of Quality in Pharmaceutical Biostatistics: One Approach to Achieving Quality Deliverables

   • Michael J. Fiola

   Biostatistics 30 December 2013 Pages: 301 - 305

6. Public Health Innovation: Biopharmaceuticals Lost in Translation?

   • Nader D. Halim
   • John J. Doyle

   Public Health 30 December 2013 Pages: 306 - 311

7. Translation and Labeling in Europe: Thoughts on the Process and Organization for Efficient Translation Sourcing

   • Matthias Heyn
   • Raun Kupiec

   Global Perspectives 30 December 2013 Pages: 312 - 326

8. Product Registration in Developing Countries: A Proposal for an Integrated Regional Licensing System Among Countries in Regional Economic Blocs

   • Yauba Saidu
   • Dario De Angelis
   • Anne Marie Georges

   Global Perspectives 30 December 2013 Pages: 327 - 335

9. Impact of In-Pharmacy Education on Patients’ Knowledge and Attitudes About Clinical Trials

   • Kenneth A. Getz

   Patient Perspectives 30 December 2013 Pages: 336 - 340

10. Chronically Ill Czech Patients’ Beliefs About Medicines: The Psychometric Properties and Factor Structure of the BMQ-CZ

    • Petra Matoulkova
    • Iva Selke Krulichova
    • Rob Horne

    Patient Perspectives 30 December 2013 Pages: 341 - 348

11. Defining Patient-Centricity: Opportunities, Challenges, and Implications for Clinical Care and Research

    • Dennis A. Robbins
    • Frederick A. Curro
    • Chester H. Fox

    Patient Perspectives 30 December 2013 Pages: 349 - 355

12. Training New-Hire Medical Information Specialists in the Pharmaceutical Industry: A Benchmarking Survey

    • Juhi Jaisinghani
    • Shrina Patel

    Drug Information 30 December 2013 Pages: 356 - 362

13. Optimizing Drug Development Programs: Type 2 Diabetes Case Study

    • Zoran Antonijevic
    • Martin Kimber
    • Klas Bergenheim

    Drug Development 30 December 2013 Pages: 363 - 374

14. Drug Development in the 21st Century: The Synergy of Public, Private, and International Collaboration

    • Frank E. Casty
    • Matthew S. Wieman

    Drug Development 30 December 2013 Pages: 375 - 383